Nano PharmaSolutions (NPS) has developed the platform nanodrug delivery technology, NanoTransformer® that generates nanoparticles of small molecule drugs without using lipids or polymers. NanoTransformer is the only drug nanoparticle generation process that uses phase-transition technology to enhance the solubility of BCS 2 and BCS 4 APIs without the use of excipients. The cGMP manufacturing facility opens in 2024. Nano PharmaSolutions delivers CNS therapeutics through nose to bring delivery using NanoTransformer process. This clean nanotechnology can safely and effectively deliver drugs to brain through the nose because it doesn't contain other chemicals for nanoengineering.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 9853 Pacific Heights Blvd,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Harju maakond.
- HQ
- San Diego, California
Nanopharmasolutions, Inc. Questions
Nanopharmasolutions, Inc.'s website is http://www.nanopharmasolutions.com
Nanopharmasolutions, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nano-pharmasolutions-inc
Nanopharmasolutions, Inc. has
5 employees.
View email and phone details for 5
employees at Nanopharmasolutions, Inc..
Nanopharmasolutions, Inc.'s industry is
Pharmaceutical Manufacturing
Nanopharmasolutions, Inc.'s top competitors are
Danner Laboratory,
Ck Regeon,
San Diego Regional Economic Development Corporation,
Nandi Labs,
Caire Health,
Clipto.ai,
Mocasa Investment,
World Trade Center San Diego,
Nanopharm Ltd, An Aptar Pharma Company,
Trekka Therapeutics.
Nanopharmasolutions, Inc.'s categories are Pharmaceutical Manufacturing
Nanopharmasolutions, Inc.'s founding year is 2019
